China Could ‘Corner’ Biopharmaceutical Sector with New Plan, US Panel Warns
The commission says 57 deals since early 2023 are shifting capital and know-how toward Chinese firms and could deepen U.S. dependence on drug supplies.
9 Articles
9 Articles
Senate commission says China is seizing drug supply chain, pushes for congressional action - The Daily Bo Snerdley
A Senate commission warned that China is closing in on seizing control of the global drug and biopharma supply chains. The Senate National Security Commission on Emerging Biotechnology (NSCEB) released a new analysis on Thursday. It alleges that drug and biopharmaceutical companies making deals with Chinese biotech firms advance the Chinese Communist Party‘s (CCP) efforts to control the global pharmaceutical supply chain. In an analysis of 57 de…
Senate commission says China is seizing drug supply chain, pushes for congressional action
A Senate commission warned that China is closing in on seizing control of the global drug and biopharma supply chains. The Senate National Security Commission on Emerging […]
New alarm over China controlling drug supply chains
China is intensifying efforts to control the entire drug supply chain, putting the U.S. at risk of being cut off from future lifesaving treatments, the National Security Commission on Emerging Biotechnology warns in a new analysis out Thursday.Why it matters: Western drug giants have invested huge sums in Chinese biotechs to boost their product pipelines. But sharing capital and expertise could give Beijing more control over critical pharmaceuti…
Congressional Commission Warns Western Biotech Licensing Deals Shift Capital and Know-How to China Amid U.S. Screening Push
U.S. congressional commission warned that licensing agreements between Western pharmaceutical companies and Chinese biotech firms are increasingly transferring capital and scientific know-how toward China frequently at earlier, preclinical stages of drug discovery where upfront payments arrive earlier in the R&D cycle. The warning aligns with Trump administration proposals to introduce screening requirements or prohibitions on […]
Coverage Details
Bias Distribution
- 66% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium


![[your]NEWS](/_next/image?url=https%3A%2F%2Fgroundnews.b-cdn.net%2Finterests%2Ffb6dc495f74049f513563c33352175eaa0ecd509.jpg%3Fwidth%3D60&w=128&q=75)







